Go Pro

Best Stocks Under $10 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $10.00 (10 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Curaleaf stock logo

1. Curaleaf OTCMKTS:CURLF

$9.95 -0.33 (-3.24%)
As of 10/2/2026 03:59 PM Eastern

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. More about Curaleaf

Market Capitalization
$2.32 billion
Consensus Rating
Strong Buy
Volume
322,712 shares
Average Volume
221,300 shares
Today's Range
$9.60
▼
$10.35
50-Day Range
$8.35
▼
$11.90
Lynas Rare Earths stock logo

2. Lynas Rare Earths OTCMKTS:LYSDY

$8.98 +0.23 (+2.63%)
As of 10/2/2026 03:58 PM Eastern

Lynas Rare Earths Limited, together with its subsidiaries, engages in the exploration, development, mining, extraction, and processing of rare earth minerals in Australia and Malaysia. More about Lynas Rare Earths

Market Capitalization
$8.81 billion
Consensus Rating
Strong Buy
Volume
208,464 shares
Average Volume
273,541 shares
Today's Range
$8.94
▼
$9.08
50-Day Range
$8.75
▼
$12.00
Ur Energy stock logo

3. Ur Energy NYSEAMERICAN:URG

$1.05 -0.01 (-0.94%)
Closing price 10/2/2026 04:10 PM Eastern
Extended Trading
$1.06 +0.00 (+0.48%)
As of 10/2/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$421.23 million
Consensus Rating
Buy
Consensus Price Target
$2.28 (+117.1% Upside)
Volume
5.29 million shares
Average Volume
6.62 million shares
Today's Range
$1.05
▼
$1.09
Naturgy Energy Group stock logo

4. Naturgy Energy Group OTCMKTS:GASNY

$6.57 +0.12 (+1.86%)
As of 10/2/2026 03:59 PM Eastern

Naturgy Energy Group, SA, together with its subsidiaries, engages in the supply, liquefaction, regasification, transport, storage, distribution, and sale of natural gas. More about Naturgy Energy Group

P/E Ratio
21.02
Consensus Rating
Buy
Volume
63,965 shares
Average Volume
57,796 shares
Today's Range
$6.56
▼
$6.60
50-Day Range
$6.40
▼
$6.97
Centrica stock logo

5. Centrica OTCMKTS:CPYYY

$8.02 +0.15 (+1.91%)
As of 10/2/2026 03:54 PM Eastern

Centrica plc operates as an integrated energy company in the United Kingdom, Ireland, Scandinavia, North America, and internationally. More about Centrica

Market Capitalization
$9.09 billion
Consensus Rating
Buy
Volume
218,007 shares
Average Volume
165,160 shares
Today's Range
$7.96
▼
$8.11
50-Day Range
$7.88
▼
$8.68
Hensoldt stock logo

6. Hensoldt OTCMKTS:HAGHY

$8.87 +0.22 (+2.54%)
As of 10/2/2026 03:59 PM Eastern

HENSOLDT AG, together with its subsidiaries, provides defense and security electronic sensor solutions worldwide. It offers air surveillance, airborne, ground based, security, naval and coastal, and space radars; identification friend or foe and secure data links; and commercial shipping solutions. More about Hensoldt

Market Capitalization
$9.99 billion
Consensus Rating
Buy
Volume
74,499 shares
Average Volume
141,564 shares
Today's Range
$8.75
▼
$8.94
50-Day Range
$8.48
▼
$11.07
iBio stock logo

7. iBio NASDAQ:IBIO

$1.12 +0.02 (+1.35%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$1.10 -0.02 (-2.22%)
As of 10/2/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBio

Market Capitalization
$71.38 million
Consensus Rating
Buy
Consensus Price Target
$5.29 (+369.8% Upside)
Volume
531,249 shares
Average Volume
497,827 shares
Today's Range
$1.07
▼
$1.15
Aclaris Therapeutics stock logo

8. Aclaris Therapeutics NASDAQ:ACRS

$4.39 -0.02 (-0.45%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$4.34 -0.05 (-1.14%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris Therapeutics

Market Capitalization
$616.62 million
Consensus Rating
Buy
Consensus Price Target
$11.33 (+158.2% Upside)
Volume
6.21 million shares
Average Volume
2.88 million shares
Today's Range
$4.21
▼
$4.52
Neostellar Capital stock logo

9. Neostellar Capital NASDAQ:NSLR

$7.44 -0.03 (-0.40%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$7.45 +0.01 (+0.11%)
As of 10/2/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SuRo Capital Corp. is a business development company. The firm seeks to invest in growing, late stage, venture capital-backed private companies. More about Neostellar Capital

Market Capitalization
$197.76 million
P/E Ratio
1.85
Consensus Rating
Buy
Consensus Price Target
$14.50 (+94.9% Upside)
Volume
282,167 shares
Average Volume
528,269 shares
Shattuck Labs stock logo

10. Shattuck Labs NASDAQ:STTK

$6.73 -0.11 (-1.61%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$6.63 -0.10 (-1.44%)
As of 10/2/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Shattuck Labs, Inc, a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. More about Shattuck Labs

Market Capitalization
$675.44 million
Consensus Rating
Buy
Consensus Price Target
$13.33 (+98.1% Upside)
Volume
1.84 million shares
Average Volume
1.44 million shares
Today's Range
$6.54
▼
$7.09
Kelt Exploration stock logo

11. Kelt Exploration OTCMKTS:KELTF

$7.17 0.00 (0.00%)
As of 10/1/2026 03:33 PM Eastern

Kelt Exploration Ltd., an oil and gas company, engages in the exploration, development, and production of crude oil and natural gas resources primarily in Western Canada. More about Kelt Exploration

P/E Ratio
111.33
Consensus Rating
Buy
Volume
52,696 shares
Average Volume
60,007 shares
Today's Range
$7.15
▼
$7.21
50-Day Range
$6.69
▼
$8.06
Niagen Bioscience stock logo

12. Niagen Bioscience NASDAQ:NAGE

$2.79 +0.11 (+4.10%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$2.74 -0.05 (-1.83%)
As of 10/2/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Niagen Bioscience, Inc is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. More about Niagen Bioscience

Market Capitalization
$213.45 million
P/E Ratio
15.50
Consensus Rating
Buy
Consensus Price Target
$10.33 (+270.4% Upside)
Volume
1.57 million shares
Average Volume
425,591 shares
Dream Industrial Real Estate Investment Trust stock logo

13. Dream Industrial Real Estate Investment Trust OTCMKTS:DREUF

$8.92 +0.06 (+0.68%)
As of 10/2/2026 10:39 AM Eastern

Dream Industrial REIT is an unincorporated, open-ended real estate investment trust. As at December 31, 2023, we own, manage and operate a global portfolio of well-located, diversified industrial properties comprising 327 assets totalling approximately 71.4 million square feet of GLA in key markets across Canada, Europe and the U.S. More about Dream Industrial Real Estate Investment Trust

P/E Ratio
8.76
Consensus Rating
Buy
Volume
59,260 shares
Average Volume
61,485 shares
Today's Range
$8.92
▼
$8.92
50-Day Range
$8.86
▼
$10.40
Alpha Cognition stock logo

14. Alpha Cognition NASDAQ:ACOG

$9.10 +0.40 (+4.60%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$9.24 +0.15 (+1.59%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. More about Alpha Cognition

Market Capitalization
$189.47 million
Consensus Rating
Buy
Consensus Price Target
$18.00 (+97.8% Upside)
Volume
194,450 shares
Average Volume
101,089 shares
Today's Range
$8.70
▼
$9.43
Global Net Lease stock logo

15. Global Net Lease NYSE:GNL

$8.26 +0.02 (+0.18%)
Closing price 10/2/2026 03:59 PM Eastern
Extended Trading
$8.26 0.00 (0.00%)
As of 10/2/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Global Net Lease, Inc (NYSE: GNL) is a publicly traded real estate investment trust listed on the NYSE. The firm focused on acquiring a diversified global portfolio of commercial properties, with an emphasis on sale-leaseback transactions involving single tenant, mission critical income producing net-leased assets across the United States, Western and Northern Europe.

Market Capitalization
$1.74 billion
Consensus Rating
Buy
Consensus Price Target
$10.25 (+24.2% Upside)
Volume
2.71 million shares
Average Volume
2.54 million shares
Today's Range
$8.22
▼
$8.40
Lexeo Therapeutics stock logo

16. Lexeo Therapeutics NASDAQ:LXEO

$3.53 -0.09 (-2.49%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$3.54 +0.01 (+0.20%)
As of 10/2/2026 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Lexeo Therapeutics, Inc operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. More about Lexeo Therapeutics

Market Capitalization
$297.01 million
Consensus Rating
Buy
Consensus Price Target
$18.13 (+413.5% Upside)
Volume
2.59 million shares
Average Volume
1.58 million shares
Today's Range
$3.50
▼
$3.69
Sky Harbour Group stock logo

17. Sky Harbour Group NYSE:SKYH

$9.36 -0.12 (-1.21%)
Closing price 10/2/2026 03:59 PM Eastern
Extended Trading
$9.30 -0.05 (-0.59%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sky Harbour Group Corporation operates as an aviation infrastructure development company in the United States. It develops, leases, and manages general aviation hangars for business aircraft. More about Sky Harbour Group

Market Capitalization
$725.56 million
Consensus Rating
Buy
Consensus Price Target
$12.75 (+36.3% Upside)
Volume
251,816 shares
Average Volume
167,321 shares
Today's Range
$9.10
▼
$9.54
Larimar Therapeutics stock logo

18. Larimar Therapeutics NASDAQ:LRMR

$2.96 -0.10 (-3.27%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$2.97 +0.01 (+0.34%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Larimar Therapeutics, Inc, a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. More about Larimar Therapeutics

Market Capitalization
$317.88 million
Consensus Rating
Buy
Consensus Price Target
$10.33 (+249.1% Upside)
Volume
834,960 shares
Average Volume
1.40 million shares
Today's Range
$2.92
▼
$3.11
Citizens stock logo

19. Citizens NASDAQ:CIZN

$9.15 +0.03 (+0.33%)
As of 10/2/2026 03:59 PM Eastern

Citizens Holding Company operates as the bank holding company for The Citizens Bank of Philadelphia that provides various commercial and personal banking products and services. More about Citizens

Market Capitalization
$52.10 million
P/E Ratio
9.34
Consensus Rating
Buy
Consensus Price Target
$14.17 (+54.8% Upside)
Volume
13,432 shares
Average Volume
4,107 shares
Spartan Delta stock logo

20. Spartan Delta OTCMKTS:DALXF

$8.56 -0.23 (-2.62%)
As of 10/2/2026 01:19 PM Eastern

Spartan Delta Corp. engages in the exploration, development, and production of oil and natural gas reserves in the Western Canada. More about Spartan Delta

Consensus Rating
Buy
Volume
63,322 shares
Average Volume
59,865 shares
Today's Range
$8.49
▼
$8.57
50-Day Range
$7.77
▼
$10.10
52-Week Range
$3.62
▼
$11.52
Galiano Gold stock logo

21. Galiano Gold NYSEAMERICAN:GAU

$1.99 +0.04 (+2.05%)
Closing price 10/2/2026 04:10 PM Eastern
Extended Trading
$1.97 -0.02 (-0.95%)
As of 10/2/2026 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Galiano Gold Inc engages in the exploration and evaluation of gold properties in Canada. Its flagship asset is the Asanko Gold Mine that covers an area of approximately 21,000 hectares located in Ghana, West Africa. More about Galiano Gold

Market Capitalization
$511.01 million
P/E Ratio
7.65
Consensus Rating
Buy
Consensus Price Target
$4.25 (+113.6% Upside)
Volume
2.75 million shares
Average Volume
2.22 million shares
Achieve Life Sciences stock logo

22. Achieve Life Sciences NASDAQ:ACHV

$7.24 -0.29 (-3.85%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$7.27 +0.03 (+0.39%)
As of 10/2/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. More about Achieve Life Sciences

Market Capitalization
$774.86 million
Consensus Rating
Buy
Consensus Price Target
$15.50 (+114.1% Upside)
Volume
1.89 million shares
Average Volume
1.63 million shares
Today's Range
$7.05
▼
$7.63
AEON Biopharma stock logo

23. AEON Biopharma NASDAQ:AEON

$0.28 -0.01 (-3.79%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$0.26 -0.02 (-5.73%)
As of 10/2/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AEON Biopharma, Inc, a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder. More about AEON Biopharma

Market Capitalization
$13.92 million
P/E Ratio
1.55
Consensus Rating
Buy
Consensus Price Target
$1.67 (+497.4% Upside)
Volume
3.21 million shares
Average Volume
2.94 million shares
Perspective Therapeutics stock logo

24. Perspective Therapeutics NYSEAMERICAN:CATX

$2.76 +0.04 (+1.47%)
Closing price 10/2/2026 04:10 PM Eastern
Extended Trading
$2.78 +0.02 (+0.54%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization
$310.49 million
Consensus Rating
Buy
Consensus Price Target
$11.50 (+316.7% Upside)
Volume
2.62 million shares
Average Volume
2.28 million shares
Today's Range
$2.69
▼
$2.82
Inhibikase Therapeutics stock logo

25. Inhibikase Therapeutics NASDAQ:IKT

$2.00 +0.07 (+3.63%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$2.00 +0.00 (+0.25%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase Therapeutics

Market Capitalization
$269.30 million
Consensus Rating
Buy
Consensus Price Target
$5.40 (+170.0% Upside)
Volume
434,455 shares
Average Volume
547,569 shares
Today's Range
$1.93
▼
$2.02